RDMA Pulmonary Hypertension EU5 and Canada

Role Summary The Regional Director Medical Affairs (RDMA) position sits in in the Value & Implementation (V&I) organization, which includes GMSA and Outcomes Research The RDMA is responsible for driving execution of scientific- and medical-affairs plans for their assigned Therapeutic Area (Pulmonary Hypertension) in the countries of their assigned region (EU5 & Canada). The RDMA may chair the Regional Value and Implementation Team (RVIT) to ensure execution of agreed medical tactics and leverage best practices. They are impactful members of regional cross-functional teams, including regional Commercial, Outcomes Research, Policy, and Market Access. They engage with their network of scientific leaders in their region. This is a regionally based position (i.e., residing in one of the affiliates of the region or regional hub) in the V&I Global Medical & Scientific Affairs (V&I GMSA) organization. Responsibilities and Primary Activities Lead and guide country V&I GMSA staff to execute the annual V&I scientific and medical plan for their assigned TA. May chair the Regional Value and Implementation Team (RVIT), to ensure execution of agreed medical tactics and leverage best practices. Leads collaborative decision-making and open dialogue within the RVIT team. Setting and prioritizing V & I regional strategic goals as part of the RVIT. Consolidating and communicating regional input to global V&I teams (e.g., one-pager summaries, other input). Managing data gaps, supporting execution agility, and ensuring consistency across TAs and countries. Actively participates in meaningful, strategy-focused regional discussions within RVITs, contributing insights and driving alignment on priorities and trade-offs. Translate global V&I goals into regional priorities aligned with countries need Collaborates with in country partners, RSLs, and global TA team members to drive strategic discussion, clear prioritization, and execution efficacy - ensuring integration, consistency, and cross-regional best practice sharing across teams and functions. Ensures scientific exchange is aligned with the global scientific-communications platform. Partners with regional Commercial, Outcomes Research, Policy, and Market Access to drive development and execution of regional plans. Consolidates actionable medical insights into strategic implications from countries in their region to help re-shape priorities as needed. Engages with a network of contracted scientific leaders (SLs) and other key stakeholders (therapeutic-guideline committees, payers, public groups, government officials, medical societies) from their region to deliver excellence in scientific exchange—focused, meaningful interactions that generate clear, actionable insights to inform strategy and implementation. Supports aligned priorities, as regional TA expert, affiliate staff in engagement with their national scientific leaders. Organizes regional expert-input events to answer our company’s questions regarding how to implement new indications (e.g., advisory boards and expert-input forums). Organizes regional symposia and educational meetings. Supports countries with the development of local data-generation study concepts and protocols. Reviews Investigator-Initiated Study proposals prior to headquarters submission (ex-U.S.). Manages regional programs (patient support, educational or risk management) to support appropriate and safe utilization of our company’s medicines. Commits to innovating with new technology resources, including but not limited to AI and Genesis Required Qualifications, Skills and Experience Minimum MD, PhD or PharmD (MD preferred) and recognized medical expertise in the therapy areas of pulmonary hypertension. Five or more years of experience in country/region Medical Affairs. Strong prioritization and decision-making skills. Able to effectively collaborate with partners across divisions in a matrix environment. Excellent interpersonal, analytical, and